Abraxane and mucosal inflammation Patient Reports February 11, 2012

Abraxane Side Effects Report #5794117-7
Abraxane side effect was reported by a Pharmacist from UNITED STATES on June 12, 2008. Female patient, 77 years of age, weighting 132.3 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, blood albumin decreased, heart rate increased, mucosal inflammation, nausea , neuropathy peripheral, oedema peripheral, protein total decreased. Abraxane dosage: ONE DOSE (390 MG) PRIOR TO SAE. (Q 3 WKS), INTRAVENOUS. During the same period patient was treated with LEVAQUIN, PHENERGAN, ASPIRIN, ZOMETA. Patient recovered.

Abraxane Side Effects Report #5832099-X
Abraxane side effect was reported by a Pharmacist from UNITED STATES on July 17, 2008. Female patient, 77 years of age, weighting 123.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: ascites, heart rate increased, hypoaesthesia, mucosal inflammation, nausea , neuropathy peripheral. Abraxane dosage: ONE DOSE (390 MG) PRIOR TO SAE. (Q 3 WKS),INTRAVENOUS. During the same period patient was treated with LEVAQUIN, PHENERGAN, ASPIRIN, ZOMETA, VITAMIN. Patient recovered.

Abraxane Side Effects Report #5107994-X
Abraxane side effect was reported by a Health Professional from UNITED STATES on Sept 12, 2006. Female patient, 66 years of age, weighting 163.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, disease progression, globulins increased, metastases to liver, mucosal inflammation, myalgia, oral candidiasis, pancytopenia, sepsis . Abraxane dosage: 470 MG ONCE (260 MG/M2, X 1), INTRAVENOUS DRIP. During the same period patient was treated with VICODIN, XELODA, EFFEXOR, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient died on 03/26/2006.

Abraxane Side Effects Report #5108520-1
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2006. Female patient, 66 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, blood albumin decreased, blood glucose increased, disease progression, mucosal inflammation, oral candidiasis, pancytopenia, sepsis . Abraxane dosage: 470 MG ONCE (260 MG/M2, X 1). During the same period patient was treated with VICODIN, XELODA, VENLAFAXINE, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient died.


Abraxane Side Effects Report #4818625-8
Abraxane side effect was reported by a Physician from UNITED STATES on July 27, 2005. Female patient, 54 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: hepatic failure, mucosal inflammation, white blood cell count decreased. Abraxane dosage: 260 MG/M2, INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5407897-7
Abraxane side effect was reported by a Physician from UNITED STATES on July 26, 2007. Female patient, 49 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: mucosal inflammation, neutropenia, palmar-plantar erythrodysaesthesia syndrome, recall phenomenon, white blood cell count decreased. Abraxane dosage: 225 MG/M2 INTRAVENOUS. During the same period patient was treated with NEULASTA, ZOMETA, ALTACE, DOXIL, GEMZAAR. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5097127-0
Abraxane side effect was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, 46 years of age, weighting 182.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: mucosal inflammation, neutropenia, oesophagitis, oral candidiasis, thrombocytopenia. Abraxane dosage: 507 MG DAY/1 DOSE, INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5049775-1
Abraxane side effect was reported by a Health Professional from UNITED STATES on June 22, 2006. Female patient, 45 years of age, weighting 160.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: catheter related infection, dehydration, mucosal inflammation, neutropenia, oral mucosal blistering, rash , sepsis , thrombocytopenia. Abraxane dosage: unknown. During the same period patient was treated with CARBOPLATIN, NEULASTA. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5319046-4
Abraxane side effect was reported by a Physician from UNITED STATES on Apr 16, 2007. Female patient, 59 years of age, weighting 319.7 lb, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, mucosal inflammation, pain , pharyngolaryngeal pain. Abraxane dosage: unknown. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #5325859-5
Abraxane side effect was reported by a Physician from UNITED STATES on Apr 25, 2007. Female patient, 59 years of age, weighting 145.0 lb, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, leukopenia, liver function test abnormal, mucosal inflammation, pain , pharyngolaryngeal pain. Abraxane dosage: LAST DOSE PRIOR TO SAE (CYCLE 2, 110 MG/M2) , INTRAVENOUS. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #6035351-0
Abraxane side effect was reported by a Health Professional from UNITED STATES on Jan 09, 2009. Female patient, weighting 166.4 lb, was diagnosed with adenocarcinoma pancreas and was treated with Abraxane. After drug was administered, patient experienced the following side effects: mucosal inflammation, neutropenia. Abraxane dosage: 174 MG D1,D8,D15/CYCLE 042. During the same period patient was treated with VANDETANIB, LOVENOX, ASCORBIC ACID. Patient was hospitalized. Patient recovered.